Medical Research News

RSS

ESMO introduces new set of principles to strengthen the communication of cancer research

The new 'ESMO Principles for Humanising Scientific Reporting' aim to strengthen the communication of oncology research, connect scientific evidence with patient relevance, and support a more patient-centered approach to cancer research communication.

22 Oct 2026

Intermittent fasting combined with exercise promotes weight loss in obese adults

A trial led by the Joint University Institute for Sport and Health shows benefits regarding weight, body fat, and cardiorespiratory fitness in people with obesity.

22 Oct 2026

Modulating GPCR signaling could help delay multiple age-related diseases

Researchers have outlined a bold plan for slowing aging by targeting one of the body's most important cellular communication systems.

22 Oct 2026

Obesity impairs key immune cells but bariatric surgery reverses damage

New Maynooth University (MU) research led by the Department of Biology's Dr Ciara Flynn, working within the research group of Prof Andrew Hogan at the Kathleen Lonsdale Institute for Human Health Research has found that obesity can impair key immune cells that help protect the body against infection and cancer.

22 Oct 2026

New survey reveals how chronic stress impacts U.S. adults

U.S. adults appear increasingly likely to view stress as an unavoidable part of daily life, according to the 2026 Stress in America™ survey by the American Psychological Association.

22 Oct 2026

Green energy revenues offer critical funding for universal health

The green energy transition presents a crucial opportunity to finance universal health coverage (UHC) in low and middle income countries, say experts in The BMJ's climate issue today.

22 Oct 2026

Young cancer survivors face critical gaps in follow-up care

Young adult cancer survivors face gaps in follow-up care caused by factors including geographic mobility and insurance changes, according to an analysis by UTHealth Houston researchers.

22 Oct 2026

Half-matched bone marrow transplants show high survival in young aplastic anemia patients

Researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins Children's Center report that bone marrow transplant using half-matched family donors achieved a 96% survival rate among children, adolescent, and young adult patients with severe aplastic anemia, a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells.

22 Oct 2026

Research shows how the brain merges faces and voices to read emotions

Communicating effectively with others involves recognizing emotions from faces and voices. How does the brain process and integrate emotional information from visuals and sounds that others display? New in JNeurosci, Olivier Collignon, from the Catholic University of Louvain, Stefania Mattioni, currently at Ghent University, and colleagues mapped responses in people's brains to faces and voices expressing different emotions.

22 Oct 2026

Australian study highlights delayed diagnosis in postpartum psychosis care

Women with postpartum psychosis are making repeated pleas for help before receiving a diagnosis, with the first Australian study of their help-seeking experiences finding many contacted health services an average of seven times before getting the care they needed.

22 Oct 2026

Zylidac Bio and Prolific Machines partner to scale Prolific’s next-generation biologics manufacturing platform to GMP production

Zylidac Bio, a fully integrated biologics CDMO within the Zydus Lifesciences Limited (Zydus) group, and Prolific Machines, a biotechnology company advancing biologics development and manufacturing through integrated optogenetics-enabled solutions delivering breakthrough yields, superior on-target quality, and precise process control, today announced a partnership to scale Prolific's platform from early development through GMP production.

From Zylidac Bio LLC 22 Oct 2026

A simple facial photograph may hold clues to cancer survival

FAHR-Face leverages AI to extract prognostic data from facial photographs, potentially transforming cancer survival predictions and clinical decision-making.

22 Oct 2026

BGI Genomics smarter stool testing detects colorectal cancer across Latin America

BGI Genomics' COLOTECT® addresses colorectal cancer in LATAM through innovative non-invasive screening, enhancing early detection and treatment efficiency.

From BGI Genomics 22 Oct 2026

Depression profile linked to disrupted sleep and poorer treatment responses

This study uncovers a circadian depression subtype, revealing links between sleep patterns, symptom severity, and antidepressant response in a large cohort.

22 Oct 2026

Needle-free mRNA vaccines protect mice against COVID-19 and flu

A needle-free vaccination method protected mice against the viruses that cause COVID-19 and flu, offering a possible new way to deliver mRNA vaccines while limiting unwanted inflammation.

22 Oct 2026

LSD speeds up brain waves and increases neural complexity, study finds

First synthesized in a laboratory in 1938 by the Swiss chemist Albert Hofmann, lysergic acid diethylamide, better known by its acronym LSD, is one of the most potent and most extensively studied psychedelics.

22 Oct 2026

New study explores psychedelic therapy for co-occurring cocaine addiction and depression

A team of UTHealth Houston researchers has been awarded a five-year, $3.4 million grant to study whether psilocybin-assisted therapy is a viable treatment option for individuals with co-occurring cocaine use disorder and major depressive disorder.

22 Oct 2026

INmune Bio establishes global commercialization framework for Ebstrocel™ through strategic agreement with Uniphar

INmune Bio Inc. (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has entered into a Master Services Agreement with Uniphar Durbin Ireland Limited (“Uniphar”) establishing a scalable framework to support international access, distribution and commercialization of Ebstrocel™, the Company’s allogeneic stromal cell therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB).

From INmune Bio 22 Oct 2026

New national trial platform aims to accelerate Alzheimer's disease prevention

Researchers from the University of California San Diego will join a collaboration as part of a federal award of up to $41 million to launch a national effort aimed at accelerating the search for treatments that could prevent or slow Alzheimer's disease.

22 Oct 2026

Digital mindfulness program cuts depression relapse risk in mothers by 26%

A free, online program developed by University of Colorado Boulder researchers has been shown to reduce risk of depression relapse by double digits among new moms and moms-to-be with a history of depression.

22 Oct 2026

1
2
3
4
...
8003
Next

Medical Research News

ESMO introduces new set of principles to strengthen the communication of cancer research

Intermittent fasting combined with exercise promotes weight loss in obese adults

Modulating GPCR signaling could help delay multiple age-related diseases

Obesity impairs key immune cells but bariatric surgery reverses damage

New survey reveals how chronic stress impacts U.S. adults

Green energy revenues offer critical funding for universal health

Young cancer survivors face critical gaps in follow-up care

Half-matched bone marrow transplants show high survival in young aplastic anemia patients

Research shows how the brain merges faces and voices to read emotions

Australian study highlights delayed diagnosis in postpartum psychosis care

Zylidac Bio and Prolific Machines partner to scale Prolific’s next-generation biologics manufacturing platform to GMP production

A simple facial photograph may hold clues to cancer survival

BGI Genomics smarter stool testing detects colorectal cancer across Latin America

Depression profile linked to disrupted sleep and poorer treatment responses

Needle-free mRNA vaccines protect mice against COVID-19 and flu

LSD speeds up brain waves and increases neural complexity, study finds

New study explores psychedelic therapy for co-occurring cocaine addiction and depression

INmune Bio establishes global commercialization framework for Ebstrocel™ through strategic agreement with Uniphar

New national trial platform aims to accelerate Alzheimer's disease prevention

Digital mindfulness program cuts depression relapse risk in mothers by 26%

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Improving healthcare sustainability through carbon data

Latest News